Porous bioabsorbable implant

US9327061B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9327061-B2
Application numberUS-58644909-A
CountryUS
Kind codeB2
Filing dateSep 21, 2009
Priority dateSep 23, 2008
Publication dateMay 3, 2016
Grant dateMay 3, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The bioabsorbable implant described has a porous body formed of bioabsorbable materials that have an in vivo life span of at least 2 weeks, preferably at least three weeks and not greater than 20 weeks, preferably no greater than ten weeks. The implant has a scaffolding structure which facilitates tissue in-growth and ultimately tissue replacement of the scaffolding structure. The implant has a radiopaque imaging agent at least at the exterior margins and an orientation plurality of radiopaque elements in the interior of implant. The implant preferably has three radiopaque elements within the interior that form a plane within the implant interior.

First claim

Opening claim text (preview).

What is claimed is: 1. An implant for a body cavity, comprising a body formed of a bioabsorbable material having a porosity sufficient to ensure tissue in-growth before significant bio-absorption of the implant, a radiopaque imaging agent which facilitates imaging of exterior margins of the implant and an interior orientation marker comprised of a plurality of radiopaque elements spaced inwardly from the exterior margins of the implant to facilitate relative orientation between the implant and a radiation source, wherein the plurality of radiopaque elements include at least three radiopaque elements arranged to form a plane within the interior of the implant wherein the plurality of radiopaque elements consists of three radiopaque elements which are located at apices of an equilateral triangle within the interior of the implant to form the plane.

Assignees

Inventors

Classifications

  • Prostheses implantable into the body · CPC title

  • Materials at least partially X-ray or laser opaque · CPC title

  • Silver, e.g. silver sulfadiazine · CPC title

  • Porous materials, {e.g. foams or sponges} · CPC title

  • A61L31/146Primary

    Porous materials, e.g. foams or sponges · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9327061B2 cover?
The bioabsorbable implant described has a porous body formed of bioabsorbable materials that have an in vivo life span of at least 2 weeks, preferably at least three weeks and not greater than 20 weeks, preferably no greater than ten weeks. The implant has a scaffolding structure which facilitates tissue in-growth and ultimately tissue replacement of the scaffolding structure. The implant has a…
Who is the assignee on this patent?
Govil Amit, Jones Michael L, Lubock Paul, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61L31/146. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).